Investor Relations Home

There are no items to display.

Stock Quote

MASI (Common Stock)
Exchange
Price
Change (%)
Volume
Data as of Copyright Nasdaq. Minimum 15 minutes delayed.

Online Investor Kit

	Masimo Reports Second Quarter 2017 Financial Results
	2016 Annual Report
	2016 Form 10K
	2017 Proxy Statement
	2017 Proxy Statement Supplement No.1
	2017 Proxy Statement Supplement No. 2

Corporate Profile

We are a global medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. We were incorporated in California in May 1989 and reincorporated in Delaware in May 1996.

Our core business is measure through motion and low perfusion arterial blood oxygen saturation and pulse rate monitoring, kno... More >>

Upcoming Events

More >>

There are currently no events to display.

Recent News

RSS Feeds | More >>

11/05/08

Summary Toggle Masimo Launches First Non-adhesive Pulse Oximetry Sensor Designed For Extremely Low Birth Weight Babies Unique design, size, and material expected to improve safety and care IRVINE, Calif., Nov.
10/27/08

Summary Toggle Masimo Reports Third Quarter 2008 Financial Results Record results mark 21st consecutive quarter of revenue growth Q3 2008 Highlights: Product revenues increased 29% to a record $66.0 million Direct (Non-OEM) Business revenues increased by 48% Shipped 30,700 new pulse oximeters and Pulse CO-Oximeters IRVINE, Calif., Oct.
10/23/08

Summary Toggle New Clinical Studies Presented at the American Society of Anesthesiology (ASA) Annual Meeting Show Masimo Technologies Provide Advanced Clinical Intelligence Masimo's Commercial Exhibit Draws More Than 2,500 Conference Attendees IRVINE, Calif., Oct.
10/17/08

Summary Toggle Five New Clinical Studies Show Value of Masimo PVI & PI Data to be presented at American Society of Anesthesiologists Annual Meeting as Masimo showcases world's first-and-only noninvasive and continuous hemoglobin (SpHb) and Oxygen Content (SpOC) monitor with live booth demonstrations IRVINE, Calif., Oct.
10/15/08

Summary Toggle Masimo to Report Third Quarter 2008 Financial Results on October 27, 2008 Conference call and webcast to begin after markets close at 2:00 p.m. PT (5:00 p.m. ET) IRVINE, Calif., Oct.
10/02/08

Summary Toggle Masimo Announces $1 Million Performance Guarantee Launches 'Fact vs. Fiction' website. IRVINE, Calif., Oct.
09/15/08

Summary Toggle Masimo Initiates Limited Release of First-Ever Noninvasive and Continuous Hemoglobin Monitors Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin Adhesive Sensors IRVINE, Calif., Sept.
09/10/08

Summary Toggle Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices IRVINE, Calif., Sept.
08/27/08

Summary Toggle Masimo Announces Dismissal of Litigation Brought by Shaklee and NIR Diagnostics IRVINE, Calif., Aug. 27 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through-Motion-and-Low-Perfusion pulse oximetry, today announced that it has settled pending litigation brought by Shaklee Corporation and NIR Diagnostics, Inc.
08/26/08

Summary Toggle Masimo to Present at Thomas Weisel Partners Healthcare Conference 2008 IRVINE, Calif., Aug.

Receive E-mail Alerts

To request a copy of the Annual Report, click here .